Hypertension rose in a retained rural cohort, with risk concentrated in older adults, women, and people with metabolic disease
A five-year follow-up in Limpopo Province, South Africa, found hypertension in nearly half of a retained cohort of rural Black adults, with prevalence rising from 43.8% at baseline to 46.9% at follow-up. The study tracked 518 participants from 2014 to 2016 and then again from 2019 to 2022, offering a rare longitudinal look at blood pressure burden in a setting where long travel distances, limited access to care, and delayed diagnosis can push cardiovascular risk upward long before a patient reaches a clinic.
The pattern was consistent and clinically familiar. Older age, central obesity, and diabetes carried the strongest associations with hypertension at both time points, and the effect sizes were substantial: age 64 years or older remained linked to hypertension at baseline and follow-up, central obesity did the same, and diabetes tracked closely alongside elevated blood pressure in both analyses. Women were more often hypertensive, and hypertensive participants were older than their normotensive peers, reinforcing the same risk profile that many primary care teams see in day-to-day practice across sub-Saharan Africa.
The data point toward a vascular and metabolic syndrome rather than an isolated blood pressure problem. Excess central adiposity promotes insulin resistance, sympathetic activation, sodium retention, and low-grade inflammation, all of which stiffen arteries and raise systemic vascular resistance. Diabetes adds endothelial dysfunction and accelerates small-vessel damage, while aging compounds arterial stiffness and impaired baroreflex control. In that context, the observed clustering of risk factors is not surprising; it is biologically coherent and clinically urgent.
Hypertension prevalence did not merely remain high. It increased.
Attrition reshaped the cohort and pushed the results toward a higher-risk survivor group
The strongest interpretive issue is not the blood pressure trend itself but who remained in the study. Substantial attrition bias emerged between baseline and follow-up, and the retained participants were not a random slice of the original population. Baseline hypertension prevalence among those retained was more than double the prevalence among those lost to follow-up, 43.8% versus 19.7%, with p < 0.001. Retained participants also had higher rates of obesity and diabetes, but lower rates of kidney disease.
That selective retention matters because it means the follow-up cohort functioned as a high-risk survivor group rather than a clean population sample. The rising prevalence therefore should not be read as a community-wide estimate for all rural Black adults in Limpopo. Instead, it reflects what happened within a cohort that appears to have retained more people with pre-existing cardiometabolic burden. Even so, the direction of travel is important for services planning. If the people most likely to remain under observation are also those carrying the heaviest vascular risk, then routine surveillance may systematically undercount those who are healthiest and overrepresent those already in the care pathway.
The adjusted models were consistent across time. Age 64 years or older remained associated with hypertension at baseline and follow-up, with adjusted odds ratios of 3.05 and 2.72 respectively. Central obesity showed similarly strong associations, with adjusted odds ratios of 2.92 at baseline and 2.60 at follow-up. Diabetes tracked closely as well, with adjusted odds ratios of 2.92 and 2.75. These are not marginal signals. They describe a durable risk structure that could be recognized in ordinary outpatient screening, if the system can reach adults before complications accumulate.
One sentence captures the bedside implication: blood pressure control in this setting cannot be separated from weight, glucose, and age-aware risk assessment.
Screening strategies in rural South Africa need to follow the biology, not just the clinic roster
The study’s setting gives the findings practical weight. Rural communities often face delayed presentation, intermittent follow-up, and limited access to chronic disease management. In that environment, hypertension often moves silently until stroke, heart failure, or kidney injury forces the issue. The persistence of risk across a five-year span suggests that screening programs should prioritize older adults, women, and people with abdominal obesity or diabetes rather than relying only on symptoms or opportunistic measurement.
Central obesity deserves particular attention because it captures the metabolic burden more accurately than body weight alone. Visceral fat is not inert storage tissue; it is metabolically active, amplifying insulin resistance and altering hormonal and inflammatory signaling. When central obesity and diabetes coexist, arterial injury becomes more likely and blood pressure becomes harder to normalize. This helps explain why both factors remained tightly associated with hypertension at both measurements in the cohort.
The gender pattern also deserves a practical reading. Women were more likely to be hypertensive in this cohort, but the article does not provide a mechanistic explanation for that difference. Even without overinterpreting the reason, the finding supports community screening that does not assume cardiovascular risk is evenly distributed across sex or age groups. In rural settings, the safest strategy is to measure rather than guess.
The study was conducted under ethical approval from the University of Limpopo, with informed consent and local permission from the Dikgale Tribal Authority. It also drew support from the AWI-Gen project and the NIH-funded framework for cardiometabolic research in African populations. Those details matter because they place the work within a broader effort to understand how noncommunicable disease accumulates in African communities that are often underrepresented in long-term cohort research.
The main caution remains the same: these findings describe a retained high-risk subgroup, not a clean census of the underlying population. Even so, the signal is strong enough to guide practice. Rural hypertension programs in similar communities should expect older age, central adiposity, and diabetes to identify the patients most likely to carry persistent blood pressure burden over time, and they should build screening systems around that reality rather than around convenience alone.